Biomarkers Products & Reviews
Biomarkers are biological markers which can be measured and evaluated to indicate a biological state. The use of biomarkers in research and diagnosis can indicate a normal or disease state or drug response of cells / tissues. Biomarkers include genetic markers, cell surface markers such as antigens, antibodies or receptors and secreted molecules such as cytokines. An assay system is required for identification of biomarkers. :
Selected Filters:
Novel Coronavirus (2019-nCoV) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293)
The Native Antigen CompanyNovel Coronavirus 2019-nCoV (SARS-CoV-2) Spike Glycoprotein (S1) is a recombinant antigen which contains the Spike protein amino acids 1-674. Spike S1 protein is manufactured in HEK293 mammalian cells, ensuring the most authentic post-translational modifications.
Novel Coronavirus (2019-nCoV) Spike Glycoprotein (S2), Sheep Fc-Tag (HEK293)
The Native Antigen CompanyNovel Coronavirus 2019-nCoV (SARS-CoV-2) Spike Glycoprotein (S2) is a recombinant antigen which contains the Spike S2 protein, amino acids 685-1211. Spike S2 is manufactured in mammalian HEK293 cells to ensure the most authentic post-translational modifications.
Conjugation Kit
The Native Antigen CompanyThe Native Antigen Company offers a selection of complementary easy-to-use antibody conjugation formats, with a wide range of labels suitable for use in most applications. On request we can also undertake custom conjugation of proteins and antibodies.
Contract and Custom Services
The Native Antigen CompanyWith decades of experience in the field of native antigen and recombinant protein production, and assay development, The Native Antigen Company is able to undertake a wide range of custom projects on your behalf. Â
SARS-CoV-2 Nucleoprotein, His-Tag (E. coli)
The Native Antigen CompanySARS-CoV-2 Nucleoprotein is a recombinant antigen manufactured in E. coli cells to high purity for use in vaccine research and immunoassay development. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 Spike Glycoprotein (S2), His-Tag (Insect Cells)
The Native Antigen CompanySARS-CoV-2 Spike Glycoprotein (S2) is a recombinant antigen which contains the Spike protein amino acids 685-1211 of subunit 2. Spike S2 protein is manufactured to high yield and purity using the Native Antigens baculovirus-insect cell platform. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 Spike-E-M Mosaic Protein, His-Tag (E. coli)
The Native Antigen CompanySARS-CoV-2 Spike-E-M Mosaic protein is a recombinant antigen manufactured in E. coli with greater than 95% purity, and containing the Spike (S), Envelope (E) and Membrane (M) immunodominant regions. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
Human Coronavirus 229E Nucleoprotein (E. coli)
The Native Antigen CompanyHuman Coronavirus 229E Nucleoprotein is a recombinant protein containing 359 amino acids derived from the nucleocapsid sequence, with a C-terminal 6xHis tag. It is manufactured in E. coli with greater than 95% purity.
Human Coronavirus NL63 Nucleoprotein (E. coli)
The Native Antigen CompanyHuman Coronavirus NL63 Nucleoprotein is a recombinant protein containing the nucleocapsid C-terminal region (130 amino acids), cloned and expressed in E. coli, and purified by affinity chromatography (nickel column) with greater than 95% purity.
Olink® Target 96 Inflammation
Olink ProteomicsThe most comprehensive, high-performance protein biomarker panel available for inflammation studies.
Olink® Target 96 Neurology
Olink ProteomicsTogether with our Neuro Exploratory panel, this provides the most comprehensive, high-performance protein biomarker solution available for neurological disease studies.
Gyrolab® Bioaffy™ 200
Gyros Protein TechnologiesGyrolab® Bioaffy™ 200, the most versatile disc in the Bioaffy range, with 112 data points and 200 nL sample volume this disc fits many different applications.
xMAP® SARS-CoV-2 Multi-Antigen IgG Assay (RUO)
LuminexThe xMAP® SARS-CoV-2 Multi-Antigen IgG Assay is a serological, multiplexed microsphere-based assay to measure the presence of IgG antibodies directed against the nucleocapsid protein (N), Receptor-Binding Domain (RBD) of the spike protein, and the S1 subunit of the spike protein (S1) of SARS-CoV-2 in human serum or plasma. The xMAP SARS-CoV-2 Multi-Antigen IgG Assay features: Broad Coverage: Detects IgG antibodies aga…
SARS-CoV-2 Nucleocapsid Antibody, clone 502
MerckSARS-CoV-2 Nucleocapsid, clone 502 Monoclonal Antibody (matched pair with clone 504)
SARS-CoV-2 Nucleocapsid Antibody, clone 503
MerckSARS-CoV-2 Nucleocapsid, clone 503 Monoclonal Antibody (matched pair with clone 504)
2019-nCoV Nucleocapsid Recombinant Antigen, full length (Ag-6)
Merck2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6)
COVID-19, MERS & SARS-CoV, Nucleoprotein Antibody, 1057
MerckCOVID-19, MERS & SARS-CoV, Nucleoprotein Antibody, 1057
COVID-19, MERS & SARS-CoV, Nucleoprotein Antibody, 1058
MerckCOVID-19, MERS & SARS-CoV, Nucleoprotein Antibody, 1058
SARS-CoV-2 Nucleocapsid Antibody, clone 504
MerckSARS-CoV-2 Nucleocapsid, clone 504 Monoclonal Antibody (matched pair with clone 502 or 503)
SARS-CoV-2 Spike humanized Antibody, clone 2A1
MerckSARS-CoV-2 Nucleocapsid, clone 2A1 Monoclonal Antibody (matched pair with clone 2C1)
SARS-CoV-2 Spike humanized Antibody, clone 2C1
MerckSARS-CoV-2 Nucleocapsid, clone 2C1 Monoclonal Antibody (matched pair with clone 2A1)
SARS-CoV-2 Nucleocapsid humanized Antibody, clone 4D8
MerckSARS-CoV-2 Nucleocapsid, clone 4D8 Monoclonal Antibody (matched pair with clone 5B7)
Anti-SARS-CoV-2 Nucleocapsid humanized Antibody, clone 5B7
MerckSARS-CoV-2 Nucleocapsid, clone 5B7 Monoclonal Antibody (matched pair with clone 4D8)
SARS-CoV-2 Nucleocapsid Antibody, clone 7B3
MerckSARS-CoV-2 Nucleocapsid,clone 7B3 Monoclonal Antibody (matched pair with clone 5D4)














